Tarlatamab

Advertisement

cGxPJobs Banner

Amgen and AstraZeneca’s IMDELLTRA-IMFINZI Improves SCLC Survival

Thousand Oaks, California, USA, September 8, 2026 Amgen and AstraZeneca have announced positive results from the Phase 3 DeLLphi-305...

By cGxPwire Editor
September 10, 2026

Read More

Advertisement

cGxPJobs

Directory